NO954573L - Melkeprodukt - Google Patents

Melkeprodukt

Info

Publication number
NO954573L
NO954573L NO954573A NO954573A NO954573L NO 954573 L NO954573 L NO 954573L NO 954573 A NO954573 A NO 954573A NO 954573 A NO954573 A NO 954573A NO 954573 L NO954573 L NO 954573L
Authority
NO
Norway
Prior art keywords
milk
dgla
gla
dairy
product
Prior art date
Application number
NO954573A
Other languages
English (en)
Other versions
NO954573D0 (no
Inventor
David Frederick Horrobin
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9422897A external-priority patent/GB9422897D0/en
Priority claimed from GBGB9425101.4A external-priority patent/GB9425101D0/en
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of NO954573D0 publication Critical patent/NO954573D0/no
Publication of NO954573L publication Critical patent/NO954573L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Melk eller melkeavledet produkt, anriket eller supplert l med GLA og/eller DGLA, og hvor melken eller det melkeavledede i produktet inneholder fra 100 mg til 30 g/100 ml, fortrinnsvis 150 mg til 5 g/100 ml og mest foretrukket fra 200 mg til 2 g/100 ml av GLA og/eller DGLA, og eventuelt også inneholder andre fettsyrer såsom ÅA, SA, EPA og DHA, i mengder fra l mg til 30 g/100 ml melk eller melkeprodukt.
NO954573A 1994-11-14 1995-11-13 Melkeprodukt NO954573L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422897A GB9422897D0 (en) 1994-11-14 1994-11-14 Fortified cows milk
GBGB9425101.4A GB9425101D0 (en) 1994-12-13 1994-12-13 Fortified milk

Publications (2)

Publication Number Publication Date
NO954573D0 NO954573D0 (no) 1995-11-13
NO954573L true NO954573L (no) 1996-05-15

Family

ID=26305976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954573A NO954573L (no) 1994-11-14 1995-11-13 Melkeprodukt

Country Status (9)

Country Link
EP (1) EP0711503A3 (no)
JP (1) JPH08205769A (no)
KR (1) KR960016729A (no)
CN (1) CN1135841A (no)
AU (1) AU3782895A (no)
CA (1) CA2162739A1 (no)
FI (1) FI955449A (no)
NO (1) NO954573L (no)
NZ (1) NZ280457A (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041324B2 (en) 1999-12-28 2006-05-09 Pronova Biocare As Drinkable omega-3 preparation and storage stabilization

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
AU2972597A (en) * 1996-06-03 1998-01-05 Croda International Plc Compositions and uses thereof
US6340485B1 (en) 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
GB9712420D0 (en) * 1997-06-13 1997-08-13 Mars Uk Ltd Food
US6331567B1 (en) 1997-06-13 2001-12-18 Mars Uk Limited Edible composition containing zinc and linoleic acid
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EA200100662A1 (ru) * 1998-12-15 2001-12-24 Американ Хоум Продактс Корпорейшн Способ и композиция для поддержания и восстановления целостности кишки
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
PT1340427E (pt) * 2000-11-13 2008-11-06 Nippon Suisan Kaisha Ltd Leites acídicos contendo epa e/ou dha
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
KR100651175B1 (ko) * 2004-10-20 2006-12-01 학교법인 건국대학교 칼슘강화 정제형 제품 및 그의 제조방법
CA2599112C (en) * 2005-02-14 2013-10-22 Suntory Limited Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
EP1714564A1 (en) * 2005-04-21 2006-10-25 N.V. Nutricia Method for treatment and prevention of respiratory insufficiency
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
CN100391353C (zh) * 2006-01-06 2008-06-04 石家庄三鹿集团股份有限公司 新生婴儿配方奶粉
US8871808B2 (en) 2006-06-22 2014-10-28 Ben-Gurion University Of The Negev Research And Development Authority Et Al. Over-production of dihomo linolenic acid by a mutant strain of Parietochloris incisa
ATE535156T1 (de) 2006-10-31 2011-12-15 Fuji Oil Co Ltd Lebensmittel oder getränk, das hoch ungesättigte fettsäure enthält, und verfahren zu seiner herstellung
EP1961311A1 (en) * 2007-02-23 2008-08-27 Belovo S.A., Egg Science & Technology Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
ES2402076T3 (es) * 2007-08-13 2013-04-26 Ben-Gurion University Of The Negev Research And Development Authority Sobreproducción de ácido dihomo-gamma linolénico por una cepa mutante de Parietochloris incisa
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CN102318859A (zh) * 2011-07-20 2012-01-18 孔凡艮 花生芽榨汁饮品生产工艺
PT3463332T (pt) * 2016-06-01 2021-06-30 Nestle Sa Dgla na profilaxia de doença alérgica
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1446431A (en) * 1972-04-20 1976-08-18 Williams J Nutritional supplement
US5324748A (en) * 1981-07-14 1994-06-28 Efamol Limited Method for enhancement of 1-series PG production
FR2522935A1 (fr) * 1982-03-10 1983-09-16 Chevalier Jacques Nouveaux produits a base de lait et de ses derives riches en acides gras polyinsatures et leur procede de preparation
DE3368377D1 (en) * 1982-04-16 1987-01-29 Nestle Sa Lipid composition for oral, enteral or parenteral feeding
US4670285A (en) 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2553261B1 (fr) 1983-10-14 1986-02-21 Bio Extraction Lait artificiel pour l'alimentation des nouveaux-nes et des jeunes enfants
AU4595985A (en) * 1984-08-10 1986-02-13 Sentrachem Limited Cancer treatment
JPS6187621A (ja) * 1984-10-05 1986-05-06 Nisshin Oil Mills Ltd:The アレルギ−性鼻炎及びアレルギ−性喘息治療薬
JPS61224932A (ja) * 1985-03-30 1986-10-06 Agency Of Ind Science & Technol ガンマリノレン酸成分添加ミルク
JPS6279732A (ja) * 1985-10-02 1987-04-13 Agency Of Ind Science & Technol ガンマリノレン酸含有トリグリセリド添加ミルク
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
CH676909A5 (no) * 1988-12-23 1991-03-28 Nestle Sa
ATE135207T1 (de) * 1989-04-04 1996-03-15 Beiersdorf Ag Mittel zur atopieprophylaxe
DE3920679A1 (de) * 1989-06-23 1991-01-10 Milupa Ag Fettmischung zur herstellung von nahrungen, insbesondere saeuglingsnahrungen
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids
FR2653972B1 (fr) * 1989-11-07 1993-07-09 Perrier Sante Sa Phase grasse pour produits alimentaires et matieres alimentaires comparables a la creme contenant ladite phase grasse et leur procede de preparation.
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
GB9213322D0 (en) 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041324B2 (en) 1999-12-28 2006-05-09 Pronova Biocare As Drinkable omega-3 preparation and storage stabilization

Also Published As

Publication number Publication date
NO954573D0 (no) 1995-11-13
FI955449A (fi) 1996-05-15
CA2162739A1 (en) 1996-05-15
JPH08205769A (ja) 1996-08-13
EP0711503A3 (en) 1997-11-26
EP0711503A2 (en) 1996-05-15
NZ280457A (en) 1997-11-24
FI955449A0 (fi) 1995-11-13
KR960016729A (ko) 1996-06-17
AU3782895A (en) 1996-05-23
CN1135841A (zh) 1996-11-20

Similar Documents

Publication Publication Date Title
NO954573L (no) Melkeprodukt
NO954726L (no) Forskårede fruktsafter
DE3485664D1 (de) Verwendung von stoffwechselprodukten von linol- und alpha-linolensaeure zur herstellung pharmazeutischer oder diaetetischer mittel zur behandlung atopischer stoerungen.
DE69620291D1 (de) Nahrungszusammensetzungen in verschiedenen Formen
CA2054358A1 (en) High acid nutritional formulations
MY116272A (en) Immunity enhancing lactic acid bacteria
NO940277L (no) Triglycerider og blandinger av slike
MY109928A (en) Fatty acid treatment
PH23248A (en) Process for the preparation of quinolone-carboxylic acid
IT1176916B (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
FR2584727B1 (fr) Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
ATE156015T1 (de) Arzneimittel zur behandlung von vulva-dystrophie oder vaginaltrockenheit
DE3778852D1 (de) Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4.
DE69637581D1 (de) Flüssig-kolostrum für milchprodukte
DE3468021D1 (en) Imidazol-2-yl mercapto alkanoic acids, process for producing the same and pharmaceutical preparations containing the same
ATE238805T1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
NO882792D0 (no) Fremstilling og anvendelse av promotere for ekspresjon av fremmed-dna i metylotrofebakterier.
SE8800988D0 (sv) Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same
FI885217A (fi) Menetelmä sisäisen rakenteen muodostamiseksi fermentoituihin maitotuotteisiin
DK0446143T3 (da) Affedtede polysaccharidderivater, fremgangsmåde til fremstilling heraf samt præparater indeholdende disse
SE8800989D0 (sv) Dietary composition and process for preparing same
NO20022361L (no) Fremgangsmåte for fremstilling av konjugert linolsyre
FR2684102B1 (fr) Procede de preparation de polyazidoalcools ainsi que de polyaminoalcools et polyazidothiols derives de ceux-ci.
ATE267526T1 (de) Mischfutter und verfahren zu seiner herstellung
IL65774A (en) Citrate of naphthylhydrofuryl and pharmaceutical compositions containing it